Evidence map›Paper›PMID 29182658›Full record

ArticlePloS one2017

High-permeability region size on perfusion CT predicts hemorrhagic transformation after intravenous thrombolysis in stroke.

Josep Puig, Gerard Blasco, Pepus Daunis-I-Estadella, Cecile van Eendendburg, María Carrillo-García, Carlos Aboud, María Hernández-Pérez, Joaquín Serena, Carles Biarnés, Kambiz Nael and 7 more

Abstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Article
  6. Article
  7. Value of pre-intervention CT perfusion imaging in acute ischemic stroke prognosis.Diagnostic and interventional radiology (Ankara, Turkey) · 2021
    Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Josep PuigResearch Unit of Diagnostic Imaging Institute (IDI), Department of Radiology [Girona Biomedical Research Institute] IDIBGI, Hospital Universitari Dr Josep Trueta, Girona, Spain.
Gerard BlascoResearch Unit of Diagnostic Imaging Institute (IDI), Department of Radiology [Girona Biomedical Research Institute] IDIBGI, Hospital Universitari Dr Josep Trueta, Girona, Spain.
Pepus Daunis-I-EstadellaDepartment of Computer Science, Applied Mathematics and Statistics, University of Girona, Girona, Spain.
Cecile van EendendburgDepartment of Neurology-IDIBGI, Dr Josep Trueta University Hospital, Girona, Spain.
María Carrillo-GarcíaDepartment of Radiology, Morales Meseguer University Hospital, Murcia, Spain.
Carlos AboudDepartment of Radiology, La Fe University Hospital, Valencia, Spain.
María Hernández-PérezStroke Unit, Germans Trias i Pujol University Hospital, Badalona, Spain.
Joaquín SerenaDepartment of Neurology-IDIBGI, Dr Josep Trueta University Hospital, Girona, Spain.
Carles BiarnésResearch Unit of Diagnostic Imaging Institute (IDI), Department of Radiology [Girona Biomedical Research Institute] IDIBGI, Hospital Universitari Dr Josep Trueta, Girona, Spain.
Kambiz NaelDepartment of Radiology, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America.
David S LiebeskindNeurovascular Imaging Research Core and UCLA Stroke Center, Los Angeles, United States of America.
Götz ThomallaDepartment of Neurology, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.
Bijoy K MenonCalgary Stroke Program, Hotchkiss Brain Institute, University of Calgary, Canada, Alberta, Canada.
Andrew DemchukCalgary Stroke Program, Hotchkiss Brain Institute, University of Calgary, Canada, Alberta, Canada.
Max WintermarkDepartment of Radiology, Neuroradiology Division, Stanford University, Palo Alto, California, United States of America.
Salvador PedrazaResearch Unit of Diagnostic Imaging Institute (IDI), Department of Radiology [Girona Biomedical Research Institute] IDIBGI, Hospital Universitari Dr Josep Trueta, Girona, Spain.
Mar CastellanosDepartment of Neurology, A Coruña University Hospital, Biomedical Research Institute, A Coruña, Spain.ORCID http://orcid.org/0000-0003-3116-1352

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveBlood-brain barrier (BBB) permeability has been proposed as a predictor of hemorrhagic transformation (HT) after tissue plasminogen activator (tPA) administration; however, the reliability of perfusion computed tomography (PCT) permeability imaging for predicting HT is uncertain. We aimed to determine the performance of high-permeability region size on PCT (HPrs-PCT) in predicting HT after intravenous tPA administration in patients with acute stroke.

methodsWe performed a multimodal CT protocol (non-contrast CT, PCT, CT angiography) to prospectively study patients with middle cerebral artery occlusion treated with tPA within 4.5 hours of symptom onset. HT was graded at 24 hours using the European-Australasian Acute Stroke Study II criteria. ROC curves selected optimal volume threshold, and multivariate logistic regression analysis identified predictors of HT.

resultsThe study included 156 patients (50% male, median age 75.5 years). Thirty-seven (23,7%) developed HT [12 (7,7%), parenchymal hematoma type 2 (PH-2)]. At admission, patients with HT had lower platelet values, higher NIHSS scores, increased ischemic lesion volumes, larger HPrs-PCT, and poorer collateral status. The negative predictive value of HPrs-PCT at a threshold of 7mL/100g/min was 0.84 for HT and 0.93 for PH-2. The multiple regression analysis selected HPrs-PCT at 7mL/100g/min combined with platelets and baseline NIHSS score as the best model for predicting HT (AUC 0.77). HPrs-PCT at 7mL/100g/min was the only independent predictor of PH-2 (OR 1, AUC 0.68, p = 0.045).

conclusionsHPrs-PCT can help predict HT after tPA, and is particularly useful in identifying patients at low risk of developing HT.

Indexed as

AgedAged, 80 and overFemaleHumansMaleStrokeThrombolytic TherapyTomography, X-Ray Computed

Identifiers

PMID29182658
PMCPMC5705117

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.